NMN IV Therapy in Tokyo: What the Evidence Shows

NMN IV therapy has attracted attention as a way to support NAD+ levels and healthy aging. However, the evidence needs to be interpreted carefully.

NMN, or nicotinamide mononucleotide, is used by the body to produce NAD+, a molecule involved in energy metabolism, cellular stress responses, and DNA repair. Human studies suggest that NMN can raise blood NAD+ levels, but this does not automatically mean that it reverses aging or prevents disease.

This article explains what Pitonne’s NMN IV therapy includes, what human research has found, and what remains uncertain.

What Is NMN?

NMN is a naturally occurring compound that acts as a precursor to nicotinamide adenine dinucleotide, commonly called NAD+.

NAD+ supports several cellular processes, including:

Energy metabolism
Cellular stress responses
DNA repair pathways
The activity of enzymes such as sirtuins

NAD+ levels may change with age, which has led researchers to study NMN as a possible way to support NAD+ production.

Most human research has examined oral NMN supplements. Evidence specifically involving intravenous NMN remains limited.

What Does Pitonne’s NMN IV Therapy Include?

Pitonne provides a physician-guided NMN IV therapy containing 300 mg of NMN. Treatment is considered after an online medical consultation and is adjusted according to the patient’s health condition and wellness goals.

Appointments may be available at the Pitonne clinic or through mobile visits to a home, hotel, or office in the service area. Pitonne: IV Therapy

The 300 mg dose is notable because it is the same dose examined in a small published intravenous NMN study. However, one study does not establish an ideal dose or treatment schedule for every patient.

What Has an Intravenous NMN Study Found?

A 2022 exploratory study examined a single 300 mg NMN infusion in 10 healthy adults.

The NMN was mixed with 100 mL of saline. Researchers monitored the participants for five hours and measured blood pressure, pulse, electrocardiograms, blood cells, and markers related to the liver, kidneys, heart, and pancreas.

The study reported that:

Blood-cell NAD+ levels increased after the infusion
The increase was observed mainly between 30 minutes and three hours
No significant short-term changes were found in the monitored organ or blood-cell markers
No serious acute reaction was reported among the 10 participants

However, this was an open-label study without a placebo group. It involved only 10 healthy people and evaluated a single infusion over a short observation period. It cannot confirm long-term safety, the effects of repeated treatment, or clinical anti-aging benefits. Published intravenous NMN study

What Do Oral NMN Studies Show?

Several randomized trials have studied oral NMN, generally using daily doses for several weeks.

Some studies found that oral NMN increased blood NAD+ levels. Small trials also reported possible changes in walking performance, sleep, fatigue, or muscle insulin sensitivity in specific groups.

These findings are not consistent across all studies. A 2024 systematic review of eight randomized trials involving 342 adults found no significant overall benefit for fasting glucose, insulin, HbA1c, insulin resistance, or lipid levels. Most studies lasted 12 weeks or less. Systematic review of metabolic outcomes

Another systematic review found that reported improvements in physical performance were not statistically significant overall. The available studies were small and relatively short. Systematic review of physical performance

Because these studies used oral NMN, their results cannot be assumed to apply directly to NMN given intravenously.

What Has Not Been Proven?

Current human evidence does not establish that NMN IV therapy can:

Reverse aging
Extend human lifespan
Prevent cancer, dementia, diabetes, or cardiovascular disease
Produce lasting improvements in energy or physical performance
Replace sleep, nutrition, exercise, or standard medical care
Treat unexplained fatigue without evaluating its cause

An increase in NAD+ is a laboratory finding. It is not the same as proving that a person will feel better or experience a long-term health benefit.

What Remains Unknown About Repeated NMN Infusions?

The published intravenous study evaluated one infusion in 10 healthy adults. Important questions remain unanswered, including:

The ideal dose for different patients
The most appropriate treatment interval
The effects of repeated or long-term infusions
Whether higher NAD+ levels produce meaningful clinical benefits
Safety in people with significant medical conditions
Interactions with medications or other wellness treatments

There is currently no universally established, evidence-based schedule for NMN IV therapy. Frequency should therefore be considered individually rather than promised as a standard anti-aging program.

What Should You Discuss Before Treatment?

Before NMN IV therapy, tell the nurse or physician about:

Your reason for considering NMN
Current symptoms, including persistent fatigue
Prescription and over-the-counter medications
Vitamins and supplements
Liver, kidney, heart, or metabolic conditions
A current or previous cancer diagnosis
Pregnancy or breastfeeding
Previous use of NMN or NAD+ products
Recent blood test results

If you have persistent fatigue, weight loss, pain, neurological changes, or another unexplained symptom, medical evaluation may be more important than starting a wellness infusion.

Frequently Asked Questions

Does NMN IV therapy increase NAD+?

A small study found increased NAD+ levels in blood cells after a single 300 mg NMN infusion. Because the study included only 10 healthy adults and had no placebo group, larger controlled studies are needed.

Is NMN IV therapy better than oral NMN?

This has not been established. There are no strong head-to-head human trials showing that intravenous NMN produces better clinical outcomes than oral NMN.

Is NMN IV therapy an anti-aging treatment?

NMN is being studied in relation to NAD+ and aging biology, but human evidence does not show that NMN IV therapy reverses aging or extends lifespan.

How often should NMN IV therapy be given?

There is no established evidence-based schedule. The available intravenous study evaluated a single infusion, so repeated treatment should be considered individually after medical review.

Conclusion

Pitonne’s NMN IV therapy contains 300 mg of NMN and is provided following a physician-guided consultation.

A small human study suggests that a single 300 mg infusion can temporarily increase blood-cell NAD+ levels without significant short-term changes in the monitored laboratory markers. However, long-term safety, repeated dosing, and meaningful anti-aging benefits have not been established.

Before booking NMN IV therapy in Tokyo, discuss your health history, medications, symptoms, and expectations with the nurse or physician.

References

Related Pitonne Services

NMN IV Therapy

Contact Pitonne

Contact Pitonne to discuss clinician-guided wellness options and whether a service is appropriate for your goals.